drugset / Trial / NCT02189239

Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress

NCT02189239 ↗

Phase 4 Completed 72 enrolled Max Zeller Soehne AG
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the STRESS trial is to investigate in a mode of action setting the effect of Zeller Entspannung film coated tablets on saliva cortisol response versus Placebo after acute stress in healthy male volunteers. In addition, data on safety and tolerability of Zeller Entspannung will be obtained. A third arm including no treatment is tested as well. Approximately 72 healthy volunteers will be included into this randomized, double blind study. Study duration will be 7 days, study medication intake will be over 4 days: participants will take the medication one tablet three times a day (morning, midday, evening) the first 3 days, whereas on day 4 only two tablets will be taken (morning and midday).

Timeline

Start
2015-01
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zeller Entspannung film coated tablet Unknown 570 mg —

Indications

No indication recorded.